Citação norma APA

Alkabbani, W., & Gamble, J. (2021). Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date. Drug Des Devel Ther.

Citação norma Chicago

Alkabbani, Wajd, and John-Michael Gamble. "Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date." Drug Des Devel Ther 2021.

Citação norma MLA

Alkabbani, Wajd, and John-Michael Gamble. "Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date." Drug Des Devel Ther 2021.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.